Efficacy of Shugan Hewei Decoction in treating chronic atrophic gastritis and its influence on gastric mucosal pathology

Key Points

• Improvement in gastric mucosal pathology was noted with the use of Shugan Hewei Decoction, indicating its efficacy.
• Key biomarkers associated with chronic atrophic gastritis improved significantly after treatment with Shugan Hewei Decoction.
• Assessment focused on chronic atrophic gastritis, utilizing comprehensive gastric mucosal evaluations and pathology tests.
• Findings support the use of Shugan Hewei Decoction as a viable intervention for enhancing gastric health in affected individuals.